treatment

Researchers have identified a novel drug target with the potential to overcome drug resistance and prevent tumour regrowth in cancer patients.

Many of Britain’s 4.3 million registered diabetics face a critical medication shortage as their treatments are snapped up by dieters.

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions.

Releaf, has shared a list of surprising medical conditions that could benefit from medicinal cannabis treatment.

Research has found that SSRI treatment for postnatal depression is associated with improvements in child behaviour up to age five.

In the e­ver-changing landscape of healthcare­, personalised medicine­ has become a significant breakthrough in tre­atment.

In the fast-evolving landscape of healthcare, technology continues to reshape the way we approach medical treatments and wellness practices. 

Social anxiety is a fast-growing phenomenon which is thought to affect young people disproportionately.

Research has identified the impacts of gut microbiota on the development of various cancers, such as colorectal cancer (CRC), gastric cancer, and hepatocellular carcinoma (HCC).

In a study published in Genes & Diseases, a research team explores the potential for the use of FDA-approved hypertension and EMA-approved cough medicines to revolutionise cancer treatment.

Chiva-Som in Hua Hin, Thailand, invites guests to experience the restorative and healing effects of the natural environment.

Metastases and resistance to chemotherapy are the main causes of treatment failure and mortality in cancer patients.

A gene encoding a protein linked to tau production was found to suppress deterioration in animal models of neurodegenerative diseases similar to Alzheimer’s disease (AD).

Birmingham researchers are to set to collaborate on a study that could result in a rapid non-invasive diagnostic test to quickly and accurately identify stroke patients who need time-critical treatment before irreversible brain damage occurs.

With yet a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA) in the US, the field is beginning to show progress in the fight to slow the disease.